IRX Therapeutics

IRX Therapeutics

A company developing immune therapies for cancer and related diseases

All edits

Edits on 9 July, 2019
Golden AI"Crunchbase 2013 Snapshot (C) 2013 https://data.crunchbase.com/docs/2013-snapshot#section-using-the-snapshot"
Golden AI edited on 9 July, 2019 2:49 pm
Edits made to:
Infobox (+1 properties)
Edits on 25 April, 2019
Golden AI
Golden AI edited on 25 April, 2019 12:52 am
Edits made to:
Infobox (+2 properties)

Infobox

Edits on 30 March, 2019
Dawson Sewell
Dawson Sewell edited on 30 March, 2019 1:48 pm
Edits made to:
Infobox (+7 properties)
Categories (+1/-2 topics)
Related Topics (+1 topics)
Edits on 4 February, 2019
Thomas Shaddox"remove duplicate website"
Thomas Shaddox edited on 4 February, 2019 5:43 pm
Edits made to:
Infobox (-1 properties)
Sameeha Sulaiman
Sameeha Sulaiman edited on 4 February, 2019 2:57 pm
Edits made to:
Infobox (+1 properties)
Sameeha Sulaiman
Sameeha Sulaiman edited on 4 February, 2019 2:55 pm
Edits made to:
Article (+27/-27 characters)

Article

...

In November 2018, IRX Therapeutics was acquired by Brooklyn ImmunoTherapeuticsBrooklyn ImmunoTherapeutics.

Sameeha Sulaiman
Sameeha Sulaiman edited on 4 February, 2019 2:54 pm
Edits made to:
Article (+1017 characters)
Further reading (+2 rows) (+7 cells) (+494 characters)
Related Topics (+1 topics)

Article

IRX Therapeutics is a clinical-stage bio-pharmaceutical company developing immunotherapies focused on reducing the immune suppression that is seen in the cancer tumor microenvironment, restoring immune function, and activating a coordinated immune response against the tumor.

The company's lead product candidate, IRX-2, is a proprietary therapeutic containing numerous active cytokine components. Studies indicate that IRX-2 acts to restore and activate multiple immune cell types, including T cells, dendritic cells, and natural killer cells to recognize and destroy tumors. It is a primary cell-derived biologic produced by stimulation of human peripheral blood mononuclear cells (PBMCs) obtained from healthy donor whole blood.

IRX-2 is being studied in an ongoing Phase 2B clinical trial in patients with newly diagnosed stage II, III, and IV squamous cell carcinoma of the head and neck and in preoperative early stage breast cancer.

...

In November 2018, IRX Therapeutics was acquired by Brooklyn ImmunoTherapeutics.

Further reading

Title
Author
Link
Type

IRX Therapeutics and ImmunID Announce Collaboration to Predict Response to IRX-2 Cancer Immunotherapy Using ImmunTraCkeR®

ImmunID & IRX Therapeutics

Web

Related Topics

Edits on 21 January, 2019
Golden AI"Changed markets to industries"
Golden AI edited on 21 January, 2019 10:11 pm
Edits made to:
Infobox (+1/-1 properties)

Infobox

Edits on 10 January, 2019
Golden AI
Golden AI edited on 10 January, 2019 9:45 am
Edits made to:
Infobox (+1 properties)

Infobox

Edits on 23 December, 2018
Sameeha Sulaiman
Sameeha Sulaiman edited on 23 December, 2018 10:59 am
Edits made to:
People (+3 rows) (+6 cells) (+83 characters)

People

Name
Role
Related Golden topics

James Egan

VP of Business Development

Mark Leuchtenberger

President & CEO

Monil Shah

COO

Edits on 12 December, 2018
Golden AI"Import data"
Golden AI edited on 12 December, 2018 1:11 am
Edits made to:
Infobox (+2 properties)
People (+6 rows) (+12 cells) (+122 characters)
Categories (+1 topics)

People

Name
Role
Related Golden topics

Alex Efron

Employee

David Allen

Investor

John Heilshorn

Investor

Joseph Swiader

Investor

Mark Lodish

Investor

Reza Movahedin

Employee

Infobox

Categories

Edits on 19 July, 2018
Golden AI"Update locations in infobox"
Golden AI edited on 19 July, 2018 8:51 pm

Infobox

Edits on 29 June, 2018
Golden AI"Update infobox"
Golden AI edited on 29 June, 2018 5:41 pm
Edits on 18 June, 2018
Golden AI"Updating description"
Golden AI edited on 18 June, 2018 10:51 pm
Edits made to:
Description (+69/-21 characters)
Topic thumbnail

IRX Therapeutics

Biotechnology company

A company developing immune therapies for cancer and related diseases

Edits on 29 May, 2018
Golden AI"Initial topic creation"
Golden AI created this topic on 29 May, 2018 9:34 pm
Edits made to:
Description (+21 characters)
Categories (+1 topics)
Topic thumbnail

 IRX Therapeutics

Biotechnology company

Categories

No more activity to show.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.